KELER TIBOR 4
4 · Celldex Therapeutics, Inc. · Filed Dec 9, 2022
Insider Transaction Report
Form 4
KELER TIBOR
Sr. VP & CSO
Transactions
- Sale
Common Stock, par value $0.001 per share
2022-12-07$36.93/sh−16,860$622,611→ 7,357 total - Exercise/Conversion
Common Stock, par value $0.001 per share
2022-12-07$2.78/sh+16,860$46,871→ 24,217 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2022-12-07−16,860→ 43,140 totalExercise: $2.78Exp: 2029-06-19→ Common Stock (16,860 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.69 to $37.28 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]25% vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.